Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk

被引:0
作者
Buglione, Michela [1 ]
Spiazzi, Luigi [2 ]
Saiani, Federica [2 ]
Costa, Loredana [1 ]
Shehi, Blerina [1 ]
Lazzari, Barbara [1 ]
Uccelli, Chiara [2 ]
Pasinetti, Nadia [1 ]
Borghetti, Paolo [1 ]
Triggiani, Luca [1 ]
Donadoni, Laura [1 ]
Pedretti, Sara [1 ]
Magrini, Stefano M. [1 ]
机构
[1] Univ Brescia, Dept Radiat Oncol, I-25123 Brescia, Italy
[2] Spedali Civil Brescia, Dept Med Phys, I-25125 Brescia, Italy
关键词
glioblastoma; helical intensity-modulated radiotherapy; intensity-modulated radiotherapy; radiotherapy; three-dimensional conformal radiotherapy; HIGH-GRADE GLIOMAS; RADIATION-THERAPY; INTEGRATED BOOST; SURGICAL RESECTION; MALIGNANT GLIOMAS; IMRT; IRRADIATION; TEMOZOLOMIDE; CONCOMITANT; SURVIVAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Radiotherapy is the standard treatment of glioblastoma. Three-dimensional conformal radiotherapy is the standard technique to treat glioblastoma. Intensity-modulated radiotherapy and helical intensity-modulated radiotherapy (tomotherapy) are becoming widely used. The present study compared three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and tomotherapy in terms of target coverage and preservation of organs at risk. Methods. Ten patients treated with three-dimensional conformal radiotherapy, with a target volume close to or superimposed to the organs at risk, were retrospectively selected. The plans were re-planned with step-and-shoot 3/5 fields intensity-modulated radiotherapy and tomotherapy. Target coverage and sparing of organs at risk were statistically compared. Results. Mean planning target volume V95% improved with sophisticated techniques (87.2%, 93.2%, 97.6% with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and tomotherapy, respectively). The comparison of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy did not show significant differences, whereas differences were significant when three-dimensional conformal radiotherapy and tomotherapy as well as intensity-modulated radiotherapy and tomotherapy were compared. Mean planning target volume/clinical target volume D99-D98-D95 were not different between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy, but they were different between tomotherapy and three-dimensional conformal radiotherapy and intensity-modulated radiotherapy, with better clinical target volume/ and planning target volume coverage with the tomotherapy plans. Brain D33/66 were 31.1/11.8 Gy, 37.5/18.3 Gy and 28.5/14.7 Gy with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and tomotherapy, respectively. Mean brainstem, optic nerves and chiasma Dmax were always within the defined constraints. The homogeneity index improved with intensity-modulated radiotherapy/tomotherapy compared to three-dimensional conformal radiotherapy. Tomotherapy was better than intensity-modulated radiotherapy in all patients. Conclusions. In this selected group of patients, a significant dosimetric advantage was evident for tomotherapy compared with three-dimensional conformal radiotherapy and intensity-modulated radiotherapy. Significant advantages were evident in terms of panning target volume coverage (V95), D99, D98 and D95. The clinical significance of the results should be defined.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 29 条
[1]   Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues [J].
Amelio, Dante ;
Lorentini, Stefano ;
Schwarz, Marco ;
Amichetti, Maurizio .
RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) :361-369
[2]   POST-OPERATIVE IRRADIATION OF GLIOBLASTOMAS - RESULTS IN A RANDOMIZED SERIES [J].
ANDERSEN, AP .
ACTA RADIOLOGICA ONCOLOGY, 1978, 17 (06) :475-484
[3]   An absolute dose determination of helical tomotherapy accelerator, TomoTherapy High-Art II [J].
Bailat, Claude J. ;
Buchillier, Thierry ;
Pachoud, Marc ;
Moeckli, Raphael ;
Bochud, Francois O. .
MEDICAL PHYSICS, 2009, 36 (09) :3891-3896
[4]  
Chan Maria F, 2003, Med Dosim, V28, P261, DOI 10.1016/j.meddos.2003.08.004
[5]  
Fadda G, 2013, STRAHLENTHER ONKOL, V189, P367, DOI 10.1007/s00066-012-0296-8
[6]   Conformity index:: A review [J].
Feuvret, L ;
Noël, G ;
Mazeron, JJ ;
Bey, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :333-342
[7]   Epidemiology of brain tumors [J].
Fisher, James L. ;
Schwartzbaum, Judith A. ;
Wrensch, Margaret ;
Wiemels, Joseph L. .
NEUROLOGIC CLINICS, 2007, 25 (04) :867-+
[8]   Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma [J].
Gerstein, Johanna ;
Franz, Kea ;
Steinbach, Joachim P. ;
Seifert, Valker ;
Fraunholz, Inge ;
Weiss, Christian ;
Roedel, Claus .
RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) :382-386
[9]   Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: Does IMRT increase the integral dose to normal brain? [J].
Hermanto, Ulrich ;
Frija, Erik K. ;
Lii, MingFwu J. ;
Chang, Eric L. ;
Mahajan, Anita ;
Woo, Shiao Y. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1135-1144
[10]   Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT [J].
Iuchi, T ;
Hatano, K ;
Narita, Y ;
Kodama, T ;
Yamaki, T ;
Osato, K .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05) :1317-1324